Erudio Healtherudio.com
Drug
Bicalutamide trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying bicalutamide: VA STARPORT. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 7 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| VA STARPORT NCT04787744 · VA Office of Research and Development | oligometastatic prostate cancer | Phase 2/Phase 3 | 119 | 25 | Focused | Oct 29, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| FORMULA-509 NCT03141671 · Dana-Farber Cancer Institute DeepView → | prostate cancer with rising PSA after radical prostatectomy | Phase 2 | Deep | View | |||
| SWOG 1216 NCT01809691 · SWOG Cancer Research Network DeepView → | newly diagnosed metastatic hormone-sensitive prostate cancer | Phase 3 | Deep | View | |||
| PREDICT-RT NCT04513717 · NRG Oncology DeepView → | high risk prostate cancer | Phase 3 | Deep | View | |||
| PR-7 NCT00003653 · NCIC Clinical Trials Group StandardView → | prostate cancer with rising PSA after radiotherapy | Phase 3 | Standard | View | |||
| RADICALS NCT00541047 · University College, London FocusedView → | prostate cancer after radical prostatectomy | Phase 3 | Focused | View | |||
| NCT03678025 NCT03678025 · SWOG Cancer Research Network FocusedView → | Not given | Phase 3 | Focused | View | |||
| INTREPId NCT04025372 · Brigham and Women's Hospital FocusedView → | Not given | Phase 2 | Focused | View | |||